Quantitative target sizes for breast tumor detection prior to metastasis: A prerequisite to rational design of 4D scanners for breast screening

Technology in Cancer Research and Treatment

Volumn 4, Issue 1, 2005, Pages 11-21

  Vinh Hung, Vincent ^a   Gordon, Richard ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer detection; Screening

Indexed keywords

BREAST METASTASIS; BREAST TUMOR; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CONFERENCE PAPER; HUMAN; TUMOR VOLUME;

EID: 13244283034     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460500400103     Document Type: Conference Paper

References (104)

1. Gordon, R., Wirth, M., Schellenberg, J., and Sivaramakrishna R. Workshop on Alternatives to Mammography, Winnipeg, September 18-20 2004. http://www.win.trlabs.ca/wam/index.html (2004).
2. Mushlin, A. I., Kouides, R. W., and Shapiro, D. E. Estimating the Accuracy of Screening Mammography: A Meta-analysis. Am. J. Prev. Med. 14, 143-153 (1998).
3. Kopans, D. B., Moore, R. H., McCarthy, K. A., Hall, D. A., Hulka, C. A., Whitman, G. J., Slanetz, P. J., and Halpern, E. F. Positive Predictive Value of Breast Biopsy Performed as a Result of Mammography: There is No Abrupt Change at Age 50 Years. Radiology 200, 357-360 (1996).
4. Kerlikowske, K., Grady, D., Barclay, J., Sickles, E. A., Eaton, A., and Ernster, V. Positive Predictive Value of Screening Mammography by Age and Family History of Breast Cancer. J. Amer. Med. Assoc. 270, 2444-2450 (1993).
5. Kriege, M., Brekelmans, C. T., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M., Muller, S. H., Meijer, S., Oosterwijk, J. C., Beex, L. V., Tollenaar, R. A., de Koning, H. J., Rutgers, E. J., and Klijn, J. G. Efficacy of MRI and Mammography for Breast-cancer Screening in Women with a Familial or Genetic Predisposition. N. Engl. J. Med. 351, 427-437 (2004).
6. Woloshin, S., Schwartz, L. M., Byram, S. J., Sox, H. C., Fischhoff, B., and Welch, H. G. Women's Understanding of the Mammography Screening Debate. Arch. Intern. Med. 160, 1434-1440 (2000).
7. Kopans, D. B. The Breast Cancer Screening Controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40-49. Radiology 210, 4-9 (1999).
8. Smith, R. A. Breast Cancer Screening Among Women Younger Than Age 50: A Current Assessment of the Issues. CA Cancer J. Clin. 50, 312-336 (2000).
9. Miller, A. B., To, T., Baines, C. J., and Wall, C. Canadian National Breast Screening Study-2: 13-year Results of a Randomized Trial in Women Aged 50-59 Years. J. Natl. Cancer. Inst. 92, 1490-1499 (2000a).
10. Olsen, O. and Gotzsche, P. C. Screening for Breast Cancer with Mammography (Cochrane Review). Cochrane Database Syst Rev 4, CD001877 (2001).
11. Gifford, D. S. The Controversy Over Screening Mammography. Med. Health R. I. 85, 101-102 (2002).
12. Miller, A. B., To, T., Baines, C. J., and Wall, C. The Canadian National Breast Screening Study-1: Breast Cancer Mortality After 11 to 16 Years of Follow-up. A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years. Ann Intern Med 137, 305-312 (2002).
13. Kopans, D. B. The Most Recent Breast Cancer Screening Controversy About Whether Mammographic Screening Benefits Women at Any Age: Nonsense and Nonscience. Ajr Am J Roentgenol 180, 21-26 (2003).
14. Miller, A. B. Is Mammography Screening for Breast Cancer Really Not Justifiable? Recent Results Cancer Res 163, 115-128; Discussion 264-266 (2003).
15. Green, B. B. and Taplin, S. H. Breast Cancer Screening Controversies. J. Am. Board Fam. Pract. 16, 233-241 (2003).
16. Lee, C. H. Screening Mammography: Proven Benefit, Continued Controversy. Radiol. Clin. North Am. 40, 395-407 (2002).
17. Retsky, M., Demicheli, R., and Hrushesky, W. Breast Cancer Screening: Controversies and Future Directions. Curr. Opin. Obstet. Gynecol. 15, 1-8 (2003).
18. Rijnsburger, A. J., van Oortmarssen, G. J., Boer, R., Draisma, G., To, T., Miller, A. B., and de Koning, H. J. Mammography Benefit in the Canadian National Breast Screening Study-2: A Model Evaluation. Int. J. Cancer 110, 756-762 (2004).
19. Gordon, R. and Sivaramakrishna, R. Mammograms are Waldograms: Why We Need 3D Longitudinal Breast Screening [Guest Editorial]. Appl. Radiol. 28, 12-25 (1999).
20. Koscielny, S., Tubiana, M., Le, M. G., Valleron, A. J., Mouriesse, H., Contesso, G., and Sarrazin, D. Breast Cancer: Relationship Between the Size of the Primary Tumour and the Probability of Metastatic Dissemination. Br. J. Cancer 49, 709-715 (1984).
21. Sivaramakrishna, R. and Gordon, R. Detection of Breast Cancer at a Smaller Size Can Reduce the Likelihood of Metastatic Spread: A Quantitative Analysis. Acad. Radiol. 4, 8-12 (1997a).
22. Gordon, R. A New Paradigm for Medical Care in Canada: Head to Toe Screening Via the 4D Imaging Annual Checkup, A Report Invited by Mr. Roy Romanow, Commission on the Future of Health Care in Canada [http://www. umanitoba.ca/faculties/medicine/radiology/stafflist/rgordon.html], University of Manitoba, Winnipeg (2002f).
23. Verschraegen, C., Vinh-Hung, V., Cserni, G., Gordon, R., Royce, M. E., Vlastos, G. Tai, P., and Storme, G. Modeling the Effect of Tumor Size in Early Breast Cancer. Annals of Surgery, in press (2005).
24. Sun, J., Chapman, J.-A., Gordon, R., Sivaramakrishna, R., Link, M. A., and Fish, E. B. Survival from Primary Breast Cancer after Routine Clinical use of Mammography. The Breast Journal 8, 199-208 (2002).
25. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999). National Cancer Institute, DCCPS, Surveillance Research Program. Cancer Statistics Branch, Released April 2002, based on the November 2001 submission. http://seer.cancer.gov (2002).
26. Klemi, P. J., Parvinen, I., Pylkkanen, L., Kauhava, L., Immonen-Raiha, P., Rasanen, O., and Helenius, H. Significant Improvement in Breast Cancer Survival Through Population-based Mammography Screening. Breast 12, 308-313 (2003).
27. Vinh-Hung, V., Burzykowski, T., Van de Steene, J., Storme, G., and Soete, G. Post-surgery Radiation in Early Breast Cancer: Survival Analysis of Registry Data. Radiother. Oncol. 64, 281-290 (2002).
28. Vinh-Hung, V., Burzykowski, T., Cserni, G., Voordeckers, M., Van De Steene, J., and Storme, G. Functional Form of the Effect of the Numbers of Axillary Nodes on Survival in Early Breast Cancer. Int. J. Oncol. 22, 697-704 (2003c).
29. Vinh-Hung, V. and Storme, G. Gompertzian Effect of Tumor Size on Mortality in Early Breast Cancer. European Journal of Cancer Supplement 2, 170 (2004).
30. Michaelson, J. S., Silverstein, M., Sgroi, D., Cheongsiatmoy, J. A., Taghian, A., Powell, S., Hughes, K., Comegno, A., Tanabe, K. K., and Smith, B. The Effect of Tumor Size and Lymph Node Status on Breast Carcinoma Lethality. Cancer 98, 2133-2143 (2003).
31. Michaelson, J. S., Silverstein, M., Wyatt, J., Weber, G., Moore, R., Halpern, E., Kopans, D. B., and Hughes, K. Predicting the Survival of Patients with Breast Carcinoma Using Tumor Size. Cancer 95, 713-723 (2002).
32. Therneau, T. M. and Grambsch, P. M. Modeling Survival Data: Extending the Cox Model. Springer Verlag, New York (2000).
33. Agresti, A. Categorical Data Analysis, 2nd Ed. Wiley, Hoboken, NJ (2002).
34. Vinh-Hung, V. and Storme, G. From Data Mining to Biological Hypotheses: Modeling the Effect of Nodes and Tumour Size in Breast Cancer. Bulletin of the International Statistical Institute 60, 586-587 (2003).
35. Vinh-Hung, V., Verschraegen, C., Promish, D. I., Cserni, G., Van de Steene, J., Tai, P., Vlastos, G., Voordeckers, M., Storme, G., and Royce, M. Ratios of Involved Nodes in Early Breast Cancer. Breast Cancer Res. 6, R680-R688 (2004).
36. Vinh-Hung, V., Voordeckers, M., Van de Steene, J., Soete, G., Lamote, J., and Storme, G. Omission of Radiotherapy after Breast-conserving Surgery: Survival Impact and Time Trends. Radiother. Oncol. 67, 147-158 (2003a).
37. Hilsenbeck, S. G., Ravdin, P. M., de Moor, C. A., Chamness, G. C., Osborne, C. K., and Clark, G. M. Time-dependence of Hazard Ratios for Prognostic Factors in Primary Breast Cancer. Breast Cancer Res. Treat. 52, 227-237 (1998).
38. Coradini, D., Daidone, M. G., Boracchi, P., Biganzoli, E., Oriana, S., Bresciani, G., Pellizzaro, C., Tomasic, G., Di Fronzo, G., and Marubini, E. Time-dependent Relevance of Steroid Receptors in Breast Cancer. J. Clin. Oncol. 18, 2702-2709 (2000).
39. Collen, C. E. and Vinh-Hung, V. Long Term Prognostic Value of ER and PR in Early Stage Breast Cancer. Journal of Clinical Oncology (Supplement 14S) 22, 771 (2004).
40. Vinh-Hung, V. and Verschraegen, C. Breast-conserving Surgery with or Without Radiotherapy: Pooled-analysis for Risks of Ipsilateral Breast Tumor Recurrence and Mortality. J. Natl. Cancer Inst. 96, 115-121 (2004).
41. Vinh-Hung, V., Van de Steene, J., Cserni, G., Vlastos, G., Voordeckers, M., and Storme, G. Modeling the Effect of Age in T1-T2 Breast Cancer. Abstract 405. European Journal of Cancer Supplements 1, S123-S124 (2003g).
42. Sauerbrei, W. and Royston, P. Building Multivariable Prognostic and Diagnostic Models: Transformation of the Predictors by Using Fractional Polynomials. J. Roy. Stat. Soc. A. Sta. 162, 71-94 (1999).
43. Holländer, N. Estimating the Functional Form of the Effect of a Continuous Covariate on Survival Time [PhD Thesis], Dortmund University, Dortmund (2002).
44. Harrell Jr., F. E. Regression Modeling Strategies with Applications to Survival Analysis and Logistic Regression. University of Virginia, Charlottesville, VA (2000).
45. Jager, K. J., Merkus, M. P., Dekker, F. W., Boeschoten, E. W., Tijssen, J. G., Stevens, P., Bos, W. J., and Krediet, R. T. Mortality and Technique Failure in Patients Starting Chronic Peritoneal Dialysis: Results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 55, 1476-1485 (1999).
46. Verbel, D. A., Heller, G., Kelly, W. K., and Scher, H. I. Quantifying the Amount of Variation in Survival Explained by Prostate-specific Antigen. Clin. Cancer Res. 8, 2576-2579 (2002).
47. Liu, X., Minin, V., Huang, Y., Seligson, D. B., and Horvath, S. Statistical Methods for Analyzing Tissue Microarray Data. J Biopharm Stat 14, 671-685 (2004).
48. Tai, P., Yu, E., Vinh-Hung, V., Cserni, G., and Vlastos, G. Survival of Patients with Metastatic Breast Cancer: Twenty-year Data From Two SEER Registries. Bmc. Cancer 4, 60 (2004).
49. Vinh-Hung, V., Burzykowski, T., Van de Steene, J., Voordeckers, M., Lamote, J., and Storme, G. Statistical Interaction in the Survival Analysis of Early Breast Cancer Using Registry Data: Role of Breast Conserving Surgery and Radiotherapy. Tumori, in press (2005).
50. von Fournier, D., Weber, E., Hoeffken, W., Bauer, M., Kubli, F., and Barth, V. Growth Rate of 147 Mammary Carcinomas. Cancer 45, 2198-2207 (1980).
51. Spratt, J. A., von Fournier, D., Spratt, J. S., and Weber, E. E. Decelerating Growth and Human Breast Cancer. Cancer 71, 2013-2019 (1993).
52. Spratt, J. A., von Fournier, D., Spratt, J. S., and Weber, E. E. Mammographic Assessment of Buman Breast Cancer Growth and Duration. Cancer 71, 2020-2026 (1993).
53. Fournier, D. V., Kuttig, H., Kubli, F., Prager, P., Stolpe, H., Maier, A., and Huter, J. Growth Velocity of Breast Carcinoma and Radiographic "Early Diagnoses". Strahlentherapie 151, 318-332 (1976).
54. von Fournier, D., Abel, U., Spratt, J. A., Spratt, J. S., and Anton, H. W. Growth Rate of Breast Cancer, Implication for Early Detection and Therapeutic Effects. Geburtshilfe Frauenheilkd 54, 286-290 (1994).
55. Galante, E., Guzzon, A., Gallus, G., Mauri, M., Bono, A., De Carli, A., Merson, M., and Di Pietro, S. Prognostic Significance of the Growth Rate of Breast Cancer: Preliminary Evaluation on the Follow-up of 196 Breast Cancers. Tumori 67, 333-340 (1981).
56. Galante, E., Gallus, G., Guzzon, A., Bono, A., Bandieramonte, G., and Di Pietro, S. Growth Rate of Primary Breast Cancer and Prognosis: Observations on a 3- to 7-year Follow-up in 180 Breast Cancers. Br. J. Cancer 54, 833-836 (1986).
57. Kuroishi, T., Tominaga, S., Morimoto, T., Tashiro, H., Itoh, S., Watanabe, H., Fukuda, M., Ota, J., Horino, T., Ishida, T., et al. I. Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening. Jpn. J. Cancer. Res. 81, 454-462 (1990).
58. Demicheli, R., Terenziani, M., Valagussa, P., Moliterni, A., Zambetti, M., and Bonadonna, G. Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy. J. Natl. Cancer Inst. 86, 45-48 (1994).
59. Demicheli, R., Terenziani, M., and Bonadonna, G. Estimate of Tumor Growth Time for Breast Cancer Local Recurrences: Rapid Growth after Wake-up? Breast Cancer Res. Treat 51, 133-137 (1998).
60. Schemper, M. Predictive Accuracy and Explained Variation. Stat Med 22, 2299-2308 (2003).
61. Pantel, K., Muller, V., Auer, M., Nusser, N., Harbeck, N., and Braun, S. Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer. Clin. Cancer Res. 9, 6326-6334 (2003).
62. Bertucci, F., Houlgatte, R., Granjeaud, S., Nasser, V., Loriod, B., Beaudoing, E., Hingamp, P., Jacquemier, J., Viens, P., Birnbaum, D., and Nguyen, C. Prognosis of Breast Cancer and Gene Expression Profiling Using DNA Arrays. Ann. NY Acad. Sci. 975, 217-231 (2002).
63. Honorio, S., Agathanggelou, A., Schuermann, M., Pankow, W., Viacava, P., Maher, E. R., and Latif, F. Detection of RASSFIA Aberrant Promoter Hypermethylation in Sputum From Chronic Smokers and Ductal Carcinoma In Situ from Breast Cancer Patients. Oncogene 22, 147-150 (2003).
64. Taback, B., Chan, A. D., Kuo, C. T., Bostick, P. J., Wang, H. J., Giuliano, A. E., and Hoon, D. S. Detection of Occult Metastatic Breast Cancer Cells in Blood by a Multimolecular Marker Assay: Correlation with Clinical Stage of Disease. Cancer Res. 61, 8845-8850 (2001).
65. Parrella, P., Xiao, Y., Fliss, M., Sanchez-Cespedes, M., Mazzarelli, P., Rinaldi, M., Nicol, T., Gabrielson, E., Cuomo, C., Cohen, D., Pandit, S., Spencer, M., Rabitti, C., Fazio, V. M., and Sidransky, D. Detection of Mitochondrial DNA Mutations in Primary Breast Cancer and Fine-needle Aspirates. Cancer Res. 61, 7623-7626 (2001).
66. Jochelson, M. Breast Cancer Imaging: The Future. Semin. Oncol. 28, 221-228 (2001).
67. Schirner, M., Menrad, A., Stephens, A., Frenzel, T., Hauff, P., and Licha, K. Molecular Imaging of Tumor Angiogenesis. Ann. NY Acad. Sci. 1014, 67-75 (2004).
68. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-stage Breast Carcinoma. J. Natl. Cancer Inst. 84, 1875-1887 (1992).
69. Bevilacqua, P., Barbareschi, M., Verderio, P., Boracchi, P., Caffo, O., Dalla, P. P., Meli, S., Weidner, N., and Gasparini, G. Prognostic Value of Intratumoral Microvessel Density, A Measure of Tumor Angiogenesis, in Node-negative Breast Carcinoma - Results of a Multiparametric Study. Breast Cancer Res. Treat 36, 205-217 (1995).
70. Weidner, N. Current Pathologic Methods for Measuring Intratumoral Microvessel Density within Breast Carcinoma and Other Solid Tumors. Breast Cancer Res. Treat. 36, 169-180 (1995).
71. Wapnir, I. L., Barnard, N., Wartenberg, D., and Greco, R. S. The Inverse Relationship Between Microvessel Counts and Tumor Volume in Breast Cancer. The Breast Journal 7, 184-188 (2001).
72. Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe'er, J., Trent, J. M., Meltzer, P. S., and Hendrix, M. J. Vascular Channel Formation by Human Melanoma Cells In Vivo and In Vitro: Vasculogenic Mimicry. Am. J. Pathol. 155, 739-752 (1999).
73. Pezella, F., Manzotti, M., Di Bacco, A., Giuseppe, V., Nicholson, A. G., Price, R., Ratcliffe, C., Pastorino, U., Harris, A., Altman, D. G., Pilotti, S., and Veronesi, U. Evidence for Novel Non-angiogenic Pathway in Breast-cancer Metastasis. Breast Cancer Progression Working Party. Lancet 355, 1787-1788 (2000).
74. Shirakawa, H., Landsman, D., Postnikov, Y. V., and Bustin, M. NBP-45, A Novel Nucleosomal Binding Protein with a Tissue-specific and Developmentally Regulated Expression. J. Biol. Chem. 275, 6368-6374 (2000).
75. Shirakawa, K., Kobayashi, H., Heike, Y., Kawamoto, S., Brechbiel, M. W., Kasumi, F., Iwanaga, T., Konishi, F., Terada, M., and Wakasugi, H. Hemodynamics in Vasculogenic Mimicry and Angiogenesis of Inflammatory Breast Cancer Xenograft. Cancer Res 62, 560-566 (2002).
76. Shirakawa, K., Kobayashi, H., Sobajima, J., Hashimoto, D., Shimizu, A., and Wakasugi, H. Inflammatory Breast Cancer: Vasculogenic Mimicry and its Hemodynamics of an Inflammatory Breast Cancer Xenograft Model. Breast Cancer Res. 5, 136-139 (2003).
77. Demicheli, R., Retsky, M. W., Swartzendruber, D. E., and Bonadonna, G. Proposal for a New Model of Breast Cancer Metastatic Development. Ann. Oncol. 8, 1075-1080 (1997).
78. Ben Baruch, A. Host Microenvironment in Breast Cancer Development: Inflammatory Cells, Cytokines and Chemokines in Breast Cancer Progression: Reciprocal Tumor-microenvironment Interactions. Breast Cancer Res. 5, 31-36 (2003).
79. Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Risberg, B., Ben Baruch, G., and Reich, R. Coordinated Expression of Integrin Subunits. Matrix Metalloproteinases (MMP), Angiogenic Genes and Ets Transcription Factors in Advanced-stage Ovarian Carcinoma: A Possible Activation Pathway? Cancer Metastasis Rev. 22, 103-115 (2003).
80. Neumark, E., Sagi-Assif, O., Shalmon, B., Ben Baruch, A., and Witz, I. P. Progression of Mouse Mammary Tumors: MCP-I-TNFalpha Cross-regulatory Pathway and Clonal Expression of Promalignancy and Antimalignancy Factors. Int. J. Cancer 106, 879-886 (2003).
81. Schor, S. L., Schor, A. M. Phenotypic and Genetic Alterations in Mammary Stroma: Implications for Tumour Progression. Breast Cancer Res 3, 373-379 (2001).
82. Shekhar, M. P., Werdell, J., and Tait, L. Interaction with Endothelial Cells is a Prerequisite for Branching Ductal-alveolar Morphogenesis and Hyperplasia of Preneoplastic Human Breast Epithelial Cells: Regulation by Estrogen. Cancer Res. 60, 439-449 (2000).
83. Shekhar, M. P., Werdell, J., Santner, S. J., Pauley, R. J., and Tait, L. Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression. Cancer Res 61, 1320-1326 (2001).
84. Shekhar, M. P., Pauley, R., and Heppner, G. Host Microenvironment in Breast Cancer Development: Extracellular Matrix-stromal Cell Contribution to Neoplastic Phenotype of Epithelial Cells in the Breast. Breast Cancer Res. 5, 130-135 (2003).
85. Harms, S. E. Percutaneous Ablation of Breast Lesions by Radiologists and Surgeons. Breast Disease 13, 67-75 (2001).
86. Singletary, S. E. Minimally Invasive Ablation Techniques in Breast Cancer Treatment. Ann Surg Oncol 9, 319-320 (2002).
87. Sabel, M. S. In Situ Ablation of Breast Tumors. What is the State of the Art? CancerNews Newsletter (May 2002) http://www.cancernews.com/articles/ breastcancertherapies.htm
88. Vargas, H. I., Dooley, W. C., Gardner, R. A., Gonzalez, K. D., Heywang-Kobrunner, S. H., and Fenn, A. J. Success of Sentinel Lymph Node Mapping After Breast Cancer Ablation with Focused Microwave Phased Array Thermotherapy. Am. J. Surg. 186, 330-332 (2003).
89. Burak Jr., W. E., Agnese, D. M., Povoski, S. P., Yanssens, T. L., Bloom, K. J., Wakely, P. E., and Spigos, D. G. Radiofrequency Ablation of Invasive Breast Carcinoma Followed by Delayed Surgical Excision. Cancer 98, 1369-1376 (2003).
90. D'Ippolito, G., Ahmed, M., Girnun, G. D., Stuart, K. E., Kruskal, J. B., Halpern, E. F., and Goldberg, S. N. Percutaneous Tumor Ablation: Reduced Tumor Growth with Combined Radio-frequency Ablation and Liposomal Doxorubicin in a Rat Breast Tumor Model. Radiology 228, 112-118 (2003).
91. Hayashi, A. H., Silver, S. F., van der Westhuizen, N. G., Donald, J. C., Parker, C., Fraser, S., Ross, A. C., and Olivotto, I. A. Treatment of Invasive Breast Carcinoma with Ultrasound-guided Radiofrequency Ablation. Am. J. Surg. 185, 429-435 (2003).
92. Gianfelice, D., Khiat, A., Amara, M., Belblidia, A., and Boulanger, Y. MR Imaging-guided Focused US Ablation of Breast Cancer: Histopathologic Assessment of Effectiveness - Initial Experience. Radiology 227, 849-855 (2003).
93. Singletary, S. E. Radiofrequency Ablation of Breast Cancer. Am. Surg. 69, 37-40 (2003a).
94. Kerr, C. Radiofrequency Ablation for Localised Breast Cancer. Lancet Oncol. 4, 68 (2003).
95. Singletary, S. E. Feasibility of Radiofrequency Ablation for Primary Breast Cancer. Breast Cancer 10, 4-9 (2003b).
96. Fujimoto, S., Kobayashi, K., Takahashi, M., Nemoto, K., Yamamoto, I., Mutou, T., Toyasawa, T., Ashida, T., Hayashi, S., Igarashi, N., and Ohkubo, H. Clinical Pilot Studies on Pre-operative Hyperthermic Tumour Ablation for Advanced Breast Carcinoma Using an 8 MHz Radiofrequency Heating Device. Int. J. Hyperthermia. 19, 13-22 (2003).
97. Elliott, R. L., Rice, P. B., Suits, J. A., Ostrowe, A. J., and Head, J. F. Radiofrequency Ablation of a Stereotactically Localized Nonpalpable Breast Carcinoma. Am. Surg. 68, 1-5 (2002).
98. Singletary, S. E., Fornage, B. D., Sneige, N., Ross, M. I., Simmons, R., Giuliano, A., Hansen, N., Kuerer, H. M., Newman, L. A., Ames, F. C., Babiera, G., Meric, F., Hunt, K. K., Edeiken, B., and Mirza, A. N. Radiofrequency Ablation of Early-stage Invasive Breast Tumors: An Overview. Cancer J. 8, 177-180 (2002).
99. Goldberg, S. N., Girnan, G. D., Lukyanov, A. N., Ahmed, M., Monsky, W. L., Gazelle, G. S., Huertas, J. C., Stuart, K. E., Jacobs, T., Torchillin, V. P., Halpern, E. F., and Kruskal, J. B. Percutaneous Tumor Ablation: Increased Necrosis with Combined Radio-frequency Ablation and Intravenous Liposomal Doxorubicin in a Rat Breast Tumor Model. Radiology 222, 797-804 (2002).
100. Dowlat, K., Robinson, D., Schwartzberg, B., Singletary, S. E., Pass, H., Gittleman, M., and Edwards, M. 2001 Image-guided Percutaneous Breast Cancer Ablation Meeting at the American Society of Breast Surgeons. Am. J. Surg. 182, 429-433 (2001).
101. Izzo, F., Thomas, R., Delrio, P., Rinaldo, M., Vallone, P., DeChiara, A., Botti, G., D'Aiuto, G., Cortino, P., and Curley, S. A. Radiofrequency Ablation in Patients with Primary Breast Carcinoma: A Pilot Study in 26 Patients. Cancer 92, 2036-2044 (2001).
102. Boehm, T., Malich, A., Reichenbach, J. R., Fleck, M., and Kaiser, W. A. Percutaneous Radiofrequency (RF) Thermal Ablation of Rabbit Tumors Embedded in Fat: A Model for RF Ablation of Breast Tumors. Invest. Radiol. 36, 480-486 (2001).
103. Nields, M. Industry Perspective, With Emphasis on Laser Ablation of Small Tumors: Making Detection Work. Technology in Cancer Research and Treatment ?(?), ?-? (2005).
104. Vargas, H. I., Dooley, W. C., Gardner, R. A., Gonzalez, K. D., Venegas, R., Heywang-Kobrunner, S. H., and Fenn, A. J. Focused Microwave Phased Array Thermotherapy for Ablation of Early-stage Breast Cancer: Results of Thermal Dose Escalation. Ann. Surg. Oncol. 11, 139-146 (2004).